Develops respiratory infectious disease products
PREP Biopharm has raised €29M across 1 funding round, most recently a Series A round in Nov 2015. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-11-01 | Series A | €29M |
| — |
| View deal → |
